The Procter & Gamble Manufacturing Company

Form 483 issued March 10, 2017 · Browns Summit, North Carolina

Inspection
Mar 6 – Mar 10, 2017
Observations
1
Pages
1
FEI number
1033800

In short: On March 10, 2017, FDA issued a Form 483 with 1 observation to The Procter & Gamble Manufacturing Company in Browns Summit, North Carolina (FEI 1033800) after an inspection that ran Mar 6 – Mar 10, 2017. The investigators were Daveta L. Bailey and Kara D. Dobbin. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.194 (laboratory records).

At a glance

1 of 1 observations on this 483 concern laboratory controls.

Laboratory controls1

Most cited: 21 CFR 211.194(a)(8) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Laboratory records do not include the initials or signature of a second person showing that the…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at The Procter & Gamble Manufacturing Company?

FDA listed 1 observation on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.194 (laboratory records). The opening words of each observation are shown on this page.

Who inspected The Procter & Gamble Manufacturing Company?

Daveta L. Bailey and Kara D. Dobbin are named on this Form 483, for the inspection of Mar 6 – Mar 10, 2017. Each investigator has a profile showing what they cite most.

When was The Procter & Gamble Manufacturing Company inspected by FDA?

The inspection ran Mar 6 – Mar 10, 2017, and the Form 483 is dated March 10, 2017.

How do I get the full Form 483 for The Procter & Gamble Manufacturing Company?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free